| EARNINGS PER SHARE |
12. EARNINGS PER SHARE The following table sets forth the computation of basic and diluted earnings per share for the six months ended June 30, 2024 and 2025 indicated: | | | | | | | Six Months Ended June 30, | | | 2024 | | 2025 | Net income attributable to ordinary shareholders — basic | | 1,726 | | 2,438 | Eliminate the dilutive effect of interest expense of convertible senior notes | | 58 | | 54 | Net income attributable to ordinary shareholders — diluted | | 1,784 | | 2,492 | Weighted average ordinary shares outstanding — basic | | 3,138,594,148 | | 3,069,285,390 | Incremental weighted-average ordinary shares from assumed exercise of share options and nonvested restricted stocks using the treasury stock method | | 37,795,005 | | 38,725,481 | Dilutive effect of convertible senior notes | | 123,927,000 | | 130,786,730 | Weighted average ordinary shares outstanding — diluted | | 3,300,316,153 | | 3,238,797,601 | Basic earnings per share | | 0.55 | | 0.79 | Diluted earnings per share | | 0.54 | | 0.77 |
For the six months ended June 30, 2024 and 2025, the Group had securities which could potentially dilute basic earnings per share in the future, but which were excluded from the computation of diluted earnings per share as their effects would have been anti-dilutive. Such outstanding securities consist of the following at non-weighted basis: | | | | | | | As of | | | June 30, | | June 30, | | | 2024 | | 2025 | Outstanding employee options and nonvested restricted stocks | | 28,519,100 | | 39,413,700 |
|